Loading…
Nephro Care India (NEPHROCARE)₹79.95+3.03%Hospital
In the Jun 2026 quarter (consolidated), Nephro Care India reported sales of ₹29.11 Cr, up 68.6% from Jun 2025, and net profit of ₹1.62 Cr. For the year to Mar 2026, sales were ₹88.41 Cr and net profit ₹3.38 Cr.
Company filings, consolidated accounts; latest reported quarter Jun 2026
| Jun 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|
| Sales | 17.27 | 26.65 | 29.11 |
| Expenses | 16.72 | 24.71 | 25.55 |
| Operating Profit | 0.61 | 2.03 | 3.63 |
| OPM % | 3.5% | 7.6% | 12.4% |
| Other Income | 0.04 | 0.82 | 0.21 |
| Interest | 0.13 | 0.00 | 0.02 |
| Depreciation | 1.17 | 1.57 | 1.20 |
| Profit before tax | −0.66 | 1.31 | 2.63 |
| Tax % | 0.0% | 23.1% | 38.2% |
| Net Profit | −0.66 | 1.01 | 1.62 |
| EPS (Rs) | −0.38 | 0.62 | 0.97 |
| Mar 2026 | |
|---|---|
| Sales | 88.41 |
| Expenses | 80.36 |
| Operating Profit | 8.33 |
| OPM % | 9.4% |
| Other Income | 1.54 |
| Interest | 0.15 |
| Depreciation | 5.08 |
| Profit before tax | 4.65 |
| Tax % | 27.4% |
| Net Profit | 3.38 |
| EPS (Rs) | 2.05 |
| Dividend payout % | 0.0% |
| Mar 2026 | |
|---|---|
| Equity Capital | 16.45 |
| Reserves | 40.47 |
| Borrowings | 0.00 |
| Other Liabilities | 15.93 |
| Total Liabilities | 72.85 |
| Fixed Assets | 34.23 |
| CWIP | 0.44 |
| Investments | 11.76 |
| Other Assets | 26.42 |
| Inventories | 2.30 |
| Trade receivables | 6.03 |
| Cash & equivalents | 6.48 |
| Total Assets | 72.85 |
| Mar 2026 | |
|---|---|
| Cash from operating activity | 2.20 |
| Cash from investing activity | −0.42 |
| Cash from financing activity | 0.06 |
| Net cash flow | 1.84 |
| Capex | 7.68 |
| Free cash flow | −5.57 |
| CFO / OP % | 48.0% |
| Mar 2026 | |
|---|---|
| Debtor days | 25 |
| Inventory days | 31 |
| Days payable | 92 |
| Cash conversion cycle | −35 |
| Working capital days | 36 |
For the Jun 2026 quarter, Nephro Care India reported sales of ₹29.11 Cr, up 68.6% year on year and net profit of ₹1.62 Cr. The operating margin was 12.4%.
Nephro Care India's sales for the year to Mar 2026 were ₹88.41 Cr.
Net profit for the year to Mar 2026 was ₹3.38 Cr. Earnings per share over the same trailing period were ₹2.05.
Nephro Care India reported borrowings of ₹0 Cr at Mar 2026, against cash and equivalents of ₹6.48 Cr.
Cash from operations was ₹2.20 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹5.57 Cr.